Renaissance Technologies
HSCS icon

Renaissance Technologies’s Heart Test Laboratories HSCS Stock Holding History

Renaissance Technologies’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-354
Closed -$32K – 3848
2023
Q2 		$32K Buy
354
+127
+56% +$12.4K ﹤0.01% 3690
2023
Q1 		$22K Sell
227
-2
-0.9% -$270 ﹤0.01% 3808
2022
Q4 		$19K Buy
229
+73
+47% +$11.4K ﹤0.01% 3971
2022
Q3 		$18K Buy
+156
New +$26.7K ﹤0.01% 3909

Other funds holding HSCS

TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
OLVIG
Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's HSCS Position: Q3 2023 in Review

Renaissance Technologies sold out of Heart Test Laboratories (HSCS) in Q3 2023, closing a stake of 354 shares — an estimated $32K sold.

Renaissance Technologies first reported a position in HSCS in Q3 2022 and held it in 4 quarters. The position peaked at $32K in Q2 2023. 10 funds tracked by Wall St. Rank hold HSCS as of Q3 2023.

  • Renaissance Technologies reported no remaining Heart Test Laboratories position as of Q3 2023 after selling out during the quarter.
  • Renaissance Technologies sold 354 Heart Test Laboratories shares in Q3 2023, an estimated $32K.
  • Renaissance Technologies first reported a position in Heart Test Laboratories in Q3 2022 and held it in 4 quarters.
  • Renaissance Technologies's Heart Test Laboratories position peaked at $32K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q3 2023.

Based on Renaissance Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.